JAMES V CARUSO
CIK 1202770 · President & CEO · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$50.8K
Companies
5
Total Filings
36
Lifetime Open-Market Net
-$2.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLRB | President & CEO | 20,318 | $2.50 | $50.8K | $74.9K | 8 | 2026-07-08 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | President and CEO | 86,401 | $0.12 | $10.3K | $45.1K | 10 | 2021-03-05 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | President and CEO | 6,000 | — | — | $8.3K | 4 | 2016-05-23 |
| Cellectar Biosciences, Inc. (CLRB.Z) Delisted | President and CEO | 47,548 | — | — | $99.5K | 1 | 2016-04-21 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Chief Commercial Officer | 103,659 | — | — | -$2.97M | 13 | 2010-03-03 |
Recent Filings · Page 4 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-02-25 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Grant (A) | +23,873 | $0 | EDGAR |
| 2008-09-03 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Sell (S) | −10,000 | -$96.8K | EDGAR |
| 2008-02-27 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-08 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Sell (S) | −10,000 | -$56.1K | EDGAR |
| 2007-02-20 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-01-03 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Buy (P) | +2,500 | $7.6K | EDGAR |
Showing 31–36 of 36
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.